XML 49 R29.htm IDEA: XBRL DOCUMENT
v3.22.4

Revenue and Accounts Receivable Credit Concentration (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Revenue from Contract with Customer [Abstract] |
Summary of Revenue | Revenues consisted of the following (in thousands):
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
Diagnostic tests |  | $ | 34,538 |  |  | $ | 48,937 |
Services |  |  | 3,674 |  |  |  | 5,569 |
Total revenue |  | $ | 38,212 |  |  | $ | 54,506 |
Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers |
|  | Year Ended December 31, |
|  | 2022 |  |  | 2021 |
The State of Colorado |  |  | 10 | % |  |  | — |
The Big Ten Conference |  |  | — |  |  |  | 40 | %
In addit ion to the above table, we collect reimbursement on behalf of customers covered by Medicare, which accounted for 37% and 18% of the Company’s total revenue for the years ended December 31, 2022 and 2021, respectively. The Company is subject to credit risk from its accounts receivable related to services provided to its customers.
|  | As of December 31, |
|  | 2022 |  |  | 2021 |
Medicare |  |  | 23 | % |  |  | 30 | %
Astrazeneca UK |  |  | 18 | % |  |  | — |
Janssen Research and Development, LLC |  |  | — |  |  |  | 14 | %
LabCorp DD (formerly Covance) |  |  | — |  |  |  | 11 | %

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration